Table II.

Treatment initiation¹ with an ACE inhibitor or an angiotensin-II receptor antagonist by demographic and social characteristics among 226 people with screen-detected type 2 diabetes in 54 general practices in Denmark 2001–2006.

	All			Treatment initiation (410 days)
Characteristics	No.	%2	CIP3 (95% CI)	CIP difference (95% CI)
Gender
Male	117	51.8	0.55 (0.45–0.65)	Ref
Female	109	48.2	0.46 (0.37–0.56)	–0.09 (–0.23–0.05)
Age, years
40–54	40	17.7	0.36 (0.22–0.55)	Ref
55–69	186	82.3	0.54 (0.46–0.61)	0.18 (–0.01–0.36)
Cohabitant
No	52	23.2	0.53 (0.38–0.69)	Ref
Yes	172	76.8	0.49 (0.42–0.57)	–0.04 (–0.21–0.13)
Vocational training
None	60	29.3	0.59 (0.45–0.73)	Ref
1–3 years	93	45.4	0.45 (0.35–0.56)	–0.14 (–0.32–0.04)
> 3 years	52	25.4	0.42 (0.29–0.56)	–0.17 (–0.37–0.03)
Employed
No	103	46.6	0.53 (0.43–0.64)	Ref
Yes	118	53.4	0.48 (0.39–0.58)	–0.05 (–0.19–0.10)

Notes: ¹410 days after exceeded thresholds; ²of completed information. Missing data < 10%; ³cumulative initiation proportion.